Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We are missing a big piece to this puzzle - or

"If there was a business resolution to the J-3 dispute and/or there's settlement money that we're somehow not aware of, I don't think the officers would be allowed (under SEC regs) to purchase shares of Patriot if they have knowledge of this "positive" information."

It is what it is.....Would the insiders be able to trade today (based on what the deal is worth today) vs. not being able to trade (based on what the deal might be worth tomorrow due to a USTPO ruling for example)? It's the only way the insider purchases fits (keeping in mind the M/A context as well).......A 10-Q is based upon absolutes, is it not, not what ifs? Now keep in mind, though today is based upon absolutes, looking at tomorrow may provide the likely impetus for the buying of shares after the insiders have calculated all the risk IMO..........

Share
New Message
Please login to post a reply